Acumen Pharmaceuticals, Inc.(ABOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ABOS Acumen Pharmaceuticals, Inc.

交易中 11-22 12:07:07 EST

2.33

+0.02

+0.65%

最高2.38	最低2.26	成交量4.96万
今开2.30	昨收2.31	日振幅5.05%
总市值1.40亿	流通市值7,537万	总股本6,008万
成交额11.46万	换手率0.15%	流通股本3,242万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ABOS","market":"US","secType":"STK","nameCN":"Acumen Pharmaceuticals, Inc.","latestPrice":2.325,"timestamp":1732295087274,"preClose":2.31,"halted":0,"volume":49626,"delay":0,"floatShares":32418080,"shares":60079778,"eps":-1.37486,"marketStatus":"交易中","marketStatusCode":2,"change":0.015,"latestTime":"11-22 12:07:07 EST","open":2.3,"high":2.38,"low":2.2633,"amount":114626.04547319999,"amplitude":0.050519,"askPrice":2.33,"askSize":34,"bidPrice":2.32,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.37486,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1625112000000,"adjPreClose":2.31,"preHourTrading":{"tag":"盘前","latestPrice":2.31,"preClose":2.31,"latestTime":"09:29 EST","volume":801,"amount":1802.3099949,"timestamp":1732285799912},"postHourTrading":{"tag":"盘后","latestPrice":2.31,"preClose":2.31,"latestTime":"17:22 EST","volume":875,"amount":2021.25,"timestamp":1732227763452},"volumeRatio":0.625995,"impliedVol":1.4634,"impliedVolPercentile":0.7579},"requestUrl":"/m/hq/s/ABOS","defaultTab":"news","newsList":[{"id":"2484908317","title":"Acumen Pharmaceuticals, Inc.盘中异动 大幅上涨5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484908317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484908317?lang=zh_cn&edition=full","pubTime":"2024-11-20 04:09","pubTimestamp":1732046996,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日04时09分，Acumen Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.80%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.56%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120040956a2468438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120040956a2468438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ABOS"],"gpt_icon":0},{"id":"2484679702","title":"Acumen Pharmaceuticals, Inc.盘中异动 股价大跌5.00%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484679702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484679702?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:59","pubTimestamp":1731941979,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时59分，Acumen Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.00%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118225939971a7327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118225939971a7327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"2483754332","title":"Acumen Pharmaceuticals, Inc.盘中异动 大幅上涨5.14%报2.66美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483754332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483754332?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:59","pubTimestamp":1731617973,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时59分，Acumen Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.14%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.01%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045933abc2198d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115045933abc2198d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABOS","BK4539"],"gpt_icon":0},{"id":"2483386968","title":"Acumen Pharmaceuticals, Inc.盘中异动 大幅下挫5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483386968","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483386968?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:39","pubTimestamp":1731512394,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日23时39分，Acumen Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.04%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111323395598e42680&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111323395598e42680&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2482085645","title":"Acumen Pharmaceuticals, Inc.盘中异动 快速下挫5.35%报3.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482085645","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482085645?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:32","pubTimestamp":1731421939,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时32分，Acumen Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.35%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223219abba4d52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112223219abba4d52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2482899044","title":"Acumen Pharmaceuticals Inc  预计每股亏损 36 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482899044","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482899044?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:24","pubTimestamp":1731083062,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc  预计每股亏损 36 美分 - 财报前瞻Acumen Pharmaceuticals Inc ABOS.OQ ABOS.O将于11月12日公布截至2024年9月30日的财报，预计该公司的季度收入将保持不变。LSEG分析师对Acumen Pharmaceuticals Inc的平均预期是每股亏损36美分。华尔街对 Acumen Pharmaceuticals Inc 的 12 个月目标价中位数为 11.00 美元，高于其上一次收盘价 3.17 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。如有任何其他问题或反馈，请联系 RefinitivNewsSupport@thomsonreuters.com。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4T3MF20J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2482489159","title":"Acumen Pharmaceuticals Inc    预计每股亏损 36 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2482489159","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482489159?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:24","pubTimestamp":1731083062,"startTime":"0","endTime":"0","summary":"   * Acumen Pharmaceuticals Inc    将于11月12日公布截至2024年9月30日的财报，预计该公司的季度收入将保持不变。*    * LSEG分析师对Acumen Pharmaceuticals Inc的平均预期是每股亏损36美分。* 华尔街对 Acumen Pharmaceuticals Inc 的 12 个月目标价中位数为 11.00 美元，高于其上一次收盘价 3.17 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Acumen Pharmaceuticals Inc    预计每股亏损 36 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2481983355","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481983355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481983355?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:33","pubTimestamp":1730903602,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时33分，Acumen Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.00%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622332698e40de7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622332698e40de7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2481324285","title":"Acumen Pharmaceuticals, Inc.盘中异动 急速拉升5.10%报2.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481324285","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481324285?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:54","pubTimestamp":1730742886,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时54分，Acumen Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.10%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105015446971a43a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105015446971a43a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABOS","BK4539"],"gpt_icon":0},{"id":"2478801481","title":"Acumen Pharmaceuticals, Inc.盘中异动 股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478801481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478801481?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:50","pubTimestamp":1730123443,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时50分，Acumen Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.17%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215043971a2a78&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028215043971a2a78&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2478316309","title":"Acumen Pharmaceuticals, Inc.盘中异动 股价大涨5.11%报2.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478316309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478316309?lang=zh_cn&edition=full","pubTime":"2024-10-25 22:24","pubTimestamp":1729866266,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日22时24分，Acumen Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.11%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522242798e3e865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102522242798e3e865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ABOS"],"gpt_icon":0},{"id":"2477869249","title":"Acumen Pharmaceuticals, Inc.盘中异动 快速跳水5.07%报2.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477869249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477869249?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:25","pubTimestamp":1729520744,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时25分，Acumen Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.07%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021222545971a1654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021222545971a1654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","ABOS"],"gpt_icon":0},{"id":"2468508331","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘股价大涨7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468508331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468508331?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:59","pubTimestamp":1726754353,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时59分，Acumen Pharmaceuticals, Inc.股票出现波动，股价大幅上涨7.38%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.93%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919215913ab64a3c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919215913ab64a3c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2460004241","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.01%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460004241","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460004241?lang=zh_cn&edition=full","pubTime":"2024-08-20 21:39","pubTimestamp":1724161165,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日21时39分，Acumen Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.01%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082021392598e35854&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082021392598e35854&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"2460177137","title":"Acumen Pharmaceuticals, Inc.2024财年第二财季实现净利润-20.54百万美元，同比减少76.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460177137","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460177137?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:03","pubTimestamp":1723997006,"startTime":"0","endTime":"0","summary":"8月19日，Acumen Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第二财季净利润为-20.54百万美元，同比减少76.92%；其中营业收入为0.00美元，每股基本收益为-0.34美元。从资产负债表来看，Acumen Pharmaceuticals, Inc.总负债44.97百万美元，其中短期债务125000.00美元，资产负债比为0.07，流动比率为0.18。机构评级：截至2024年8月19日，当前有5家机构对Acumen Pharmaceuticals, Inc.目标价做出预测，其中目标均价为11.20美元，其中最低目标价为6.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190003439f363d15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408190003439f363d15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ABOS"],"gpt_icon":0},{"id":"2459865922","title":"美国研究综述-Allstate, bluebird bio , Vicinity Motor","url":"https://stock-news.laohu8.com/highlight/detail?id=2459865922","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459865922?lang=zh_cn&edition=full","pubTime":"2024-08-16 05:59","pubTimestamp":1723759186,"startTime":"0","endTime":"0","summary":"* Vicinity Motor Corp   ：Alliance Global Partners将其评级从买入下调至持有 以下是路透周四报导的美国公司研究报告摘要。* Cardlytics Inc   ：美国银行全球研究将目标价从4美元下调至3.5美元  * Celcuity Inc   ：杰富瑞将目标价从27美元上调至28美元 * Celcuity Inc   ：Stifel将目标价从40美元下调至39美元 * Century Therapeutics Inc   ：H.C. Wainwright将目标价从11美元下调至9美元 * Chord Energy Corp   ：Piper Sandler 将目标价从 234 美元下调至 206 美元 * Cineve","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OZK","AKYA","AEIS","EAT","ASTS","ALL","LU2326559502.SGD","CIVI","T","CNX","LU0203345920.USD","EU","CHRD","ABOS","CDLX","BRO","LU0320765489.SGD","CNVS","CAH","ADSK","BRY","LITE","BK4515","BSM","GOEV","ASH","IPSC","LU","LU0205193047.USD","APA","AMT","BILL","BLUE","ARAY","AHR","TKNO","AJG","CPT","AVB","LU1366192091.USD","BKKT","LU0289739343.SGD","AFG","ANAB","BLFS","CELC","DELL","BE","CLF","VEV"],"gpt_icon":1},{"id":"2459476411","title":"Acumen Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.37%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459476411","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459476411?lang=zh_cn&edition=full","pubTime":"2024-08-15 22:39","pubTimestamp":1723732769,"startTime":"0","endTime":"0","summary":"北京时间2024年08月15日22时39分，Acumen Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.37%。截至发稿，该股报2.65美元/股，成交量1.9363万股，换手率0.03%，振幅3.92%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815223929ab5ddb29&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240815223929ab5ddb29&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ABOS","BK4539"],"gpt_icon":0},{"id":"2459188047","title":"Acumen Pharmaceuticals, Inc.盘中异动 股价大涨5.08%报2.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459188047","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459188047?lang=zh_cn&edition=full","pubTime":"2024-08-13 23:01","pubTimestamp":1723561284,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日23时01分，Acumen Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.08%。Acumen Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.77%。Acumen Pharmaceuticals, Inc.公司简介：Acumen Pharmaceuticals Inc 是一家临床阶段生物制药公司，该公司正在开发一种新的改变疾病的方法，以针对其认为是阿尔茨海默病的一个关键潜在病因。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813230125af9743c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240813230125af9743c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0},{"id":"2459090193","title":"Acumen Pharmaceuticals Inc 公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2459090193","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459090193?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:51","pubTimestamp":1723557090,"startTime":"0","endTime":"0","summary":"   * Acumen Pharmaceuticals Inc   报告，截至6月底的季度调整后每股亏损34美分，低于去年同期的每股-28美分。六位分析师对该季度的平均预期是每股亏损 28 美分。华尔街预期为每股-33美分至-24美分。* Acumen Pharmaceuticals Inc 公布的季度每股收益为亏损 34 美分。* 该公司当季亏损 2,056 万美元。* Acumen Pharmaceuticals Inc 本季度股价上涨了 5.8%，今年迄今为止亏损了 33.3%。华尔街对 Acumen Pharmaceuticals Inc 的 12 个月目标价中位数为 14.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Acumen Pharmaceuticals Inc 公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","ABOS"],"gpt_icon":0},{"id":"2458511498","title":"Acumen Pharmaceuticals Inc    预计每股亏损 28 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458511498","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458511498?lang=zh_cn&edition=full","pubTime":"2024-08-10 01:19","pubTimestamp":1723223948,"startTime":"0","endTime":"0","summary":"   * Acumen Pharmaceuticals Inc    将于8月13日公布截至2024年6月30日的财报，预计季度收入将保持不变。*    * LSEG分析师对Acumen Pharmaceuticals Inc的平均预期是每股亏损28美分。* 华尔街对 Acumen Pharmaceuticals Inc 的 12 个月目标价中位数为 14.00 美元，高于其上一次收盘价 2.74 美元。8月9日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Acumen Pharmaceuticals Inc    预计每股亏损 28 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.acumenpharm.com","stockEarnings":[{"period":"1week","weight":-0.1149},{"period":"1month","weight":-0.175},{"period":"3month","weight":-0.2062},{"period":"6month","weight":-0.3206},{"period":"1year","weight":-0.0212},{"period":"ytd","weight":-0.3984}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Acumen Pharmaceuticals, Inc.于1996年在特拉华州注册成立。他们是一家临床阶段的生物制药公司，正在开发一种新的疾病修饰方法，以针对他们认为是阿尔茨海默病或AD的关键根本原因。阿尔茨海默病是一种进行性大脑神经退行性疾病，会导致记忆力和认知功能丧失，最终导致死亡。他们的科学创始人开创了对可溶性淀粉样蛋白β寡聚体或AbO的研究，他们是与Ab单体和淀粉样斑块不同的淀粉样蛋白β或Ab肽的球状组装体。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.065937},{"month":2,"riseRate":0.666667,"avgChangeRate":0.100669},{"month":3,"riseRate":0,"avgChangeRate":-0.207564},{"month":4,"riseRate":0,"avgChangeRate":-0.088996},{"month":5,"riseRate":0.333333,"avgChangeRate":0.035781},{"month":6,"riseRate":0.333333,"avgChangeRate":0.042157},{"month":7,"riseRate":1,"avgChangeRate":0.353182},{"month":8,"riseRate":0.5,"avgChangeRate":-0.038151},{"month":9,"riseRate":0.25,"avgChangeRate":0.046615},{"month":10,"riseRate":0.25,"avgChangeRate":-0.188172},{"month":11,"riseRate":0.25,"avgChangeRate":-0.132852},{"month":12,"riseRate":0.333333,"avgChangeRate":0.135467}],"exchange":"NASDAQ","name":"Acumen Pharmaceuticals, Inc.","nameEN":"Acumen Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Acumen Pharmaceuticals, Inc.(ABOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Acumen Pharmaceuticals, Inc.(ABOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Acumen Pharmaceuticals, Inc.,ABOS,Acumen Pharmaceuticals, Inc.股票,Acumen Pharmaceuticals, Inc.股票老虎,Acumen Pharmaceuticals, Inc.股票老虎国际,Acumen Pharmaceuticals, Inc.行情,Acumen Pharmaceuticals, Inc.股票行情,Acumen Pharmaceuticals, Inc.股价,Acumen Pharmaceuticals, Inc.股市,Acumen Pharmaceuticals, Inc.股票价格,Acumen Pharmaceuticals, Inc.股票交易,Acumen Pharmaceuticals, Inc.股票购买,Acumen Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Acumen Pharmaceuticals, Inc.(ABOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Acumen Pharmaceuticals, Inc.(ABOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}